CD8A and cancer: Macrophage migration inhibitory factor (MIF) secreted by CSCs inhibits anti-cancer immune responses via the CXCR2 pathway, increasing MDSC arginase-1 (ARG-1) expression and inhibiting CD8+T cell migration [67].